Successful Combined Intratumoral Immunotherapy of Established Murine Mesotheliomas Requires B-Cell Involvement-Reference-Cited by-同舟云学术

Successful Combined Intratumoral Immunotherapy of Established Murine Mesotheliomas Requires B-Cell Involvement

Published:2015-02 Issue:2 Volume:35 Page:100-107
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Krishnan Shruti¹,Bakker Emily¹,Lee Cassandra¹,Kissick Haydn T.²,Ireland Demelza J.³,Beilharz Manfred W.¹

Affiliation:

1. School of Pathology and Laboratory Medicine (M502), Faculty of Medicine, Dentistry and Health Sciences, The University of Western Australia, Crawley, Australia.

2. Department of Surgery, Beth Israel Deaconess Medical Centre, Harvard Medical School, Boston, Massachusetts.

3. School of Women's & Infants' Health (M550), The University of Western Australia, Crawley, Australia.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jir.2014.0054

Reference42 articles.

1. Timed Ablation of Regulatory CD4+T Cells Can Prevent Murine AIDS Progression

2. 1975–1995 Revised anti-cancer serological response: Biological significance and clinical implications

3. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF- signals in vivo

4. Primary T Cell Expansion and Differentiation In Vivo Requires Antigen Presentation by B Cells

5. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Immune System of Mesothelioma Patients: A Window of Opportunity for Novel Immunotherapies;Rare Diseases - Diagnostic and Therapeutic Odyssey;2021-09-22

2. Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma;Frontiers in Oncology;2021-06-23

3. Fully Human Antibodies for Malignant Pleural Mesothelioma Targeting;Cancers;2020-04-08

4. Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future;Frontiers in Oncology;2020-01-24

5. The double-edge role of B cells in mediating antitumor T-cell immunity: Pharmacological strategies for cancer immunotherapy;International Immunopharmacology;2016-07